mutations

Documents about mutations

• Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.#829483ClinicalTrials.gov
• Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy#825174ClinicalTrials.gov
• Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC#895085ClinicalTrials.gov
• BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension#866403ClinicalTrials.gov
• MS Detection of Somatic Mutations in Hematological Malignancies#879488ClinicalTrials.gov
• A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations#841227ClinicalTrials.gov
• Heterozygous germline <i>MSH3</i> mutations, and probably <i>MLH3</i> mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk#475780Europe PMC
• Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress#877437ClinicalTrials.gov
• U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations#485094Europe PMC
• Mutations prevalent in fusion protein signal peptides from African RSV strains#477919WIReDSpace
• Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations#915959ClinicalTrials.gov
• The Influence Of Job Mutations And Position Promotions On Employees' Work Spirit At State Savings Bank KCPS Meulaboh#1002673Economic: Journal Economic and Business
• AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations#859377ClinicalTrials.gov
• A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations#916667ClinicalTrials.gov
• Quantum Tunneling Was Behind Mutations... Elucidating DNA Tautomerization#383284Zenodo (CERN)
• Transition(s) et mutations : comment penser les transformations alimentaires ? Compte rendu de Florence Strigler, Mutations alimentaires au Laos#121812HAL (France)
• Étude des mutations microsatellites par des approches basées sur l'utilisation de séquenceurs de première, deuxième et troisième génération#370832HAL (France)
• Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations#642675Europe PMC
• CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases#994912ClinicalTrials.gov
• To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.#916019ClinicalTrials.gov
• Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy#825279ClinicalTrials.gov
• Protein language models transfer learning for the prediction of mutational effects and protein disorder#142420HAL (France)
• TCTEX1D2 mutations underlie Jeune asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport#954758Koc University Digital Collections
• Cancer mutations in RAD51 and its paralogues.#189949NCBI PubMed Central
• QTX3046 in Patients With KRAS G12D Mutations#837417ClinicalTrials.gov
• Prostate Cancer Screening in Men With Germline BRCA2 Mutations#857559ClinicalTrials.gov
• Pre-existing Kinase Domain Mutations in Ph-positive Leukemias#994091ClinicalTrials.gov
• NGS in AML Relapse#994300ClinicalTrials.gov
• Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations#804093ClinicalTrials.gov
• Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma#848947ClinicalTrials.gov
• ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC#969230ClinicalTrials.gov
• Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)#991708ClinicalTrials.gov
• Unravelling genome-wide mosaic microsatellite mutations at single-cell resolution#152627bioRxiv / medRxiv
• TLR7 mutations leading to enhanced TLR7 signaling in humans#155923PMC Full-Text (OAI)
• Mutations Conferring Aminoglycoside and Spectinomycin Resistance in Borrelia burgdorferi#377445DIALNET OAI Articles
• Low incidence of EPOR mutations in idiopathic erythrocytosis#395286HAL (France)
• Homozygous CAPN1 mutations causing a spastic-ataxia phenotype in 2 families#955267Koc University Digital Collections
• Homology modeling, pharmacophore-guided virtual screening, molecular docking, and dynamics study of potential allosteric inhibitors targeting EGFR triple resistance mutations (L858R/T790M/L718Q)#310591ARPHA OAI-PMH Endpoint
• BY002 IIT Study in R/R Acute Leukemia#870670ClinicalTrials.gov
• The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?#215411HAL (France)
• Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib#898844ClinicalTrials.gov
• Perception paysanne des mutations foncières dans le département de Takiéta (Niger)#7638HAL (France)
• GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations#123662ClinicalTrials.gov
• When Knowledge Changes: Metamorphic Testing of RAG Systems with Mutations#411104arXiv CS
• Seven mutations unlock strict synthetic methylotrophy in engineered Pseudomonas putida#471362bioRxiv / medRxiv
• Mechanisms of Enhanced Growth of Pandemic H1N1 Influenza A Virus Through PA Mutations#632080UR Research
• BRCA1 and BRCA2 mutations in central and southern Italian patients#646549PubMed Central
• Clinical Significance of Germline BRCA Mutations#832118ClinicalTrials.gov
• Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients#868062ClinicalTrials.gov
• Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer#902101ClinicalTrials.gov